How the 9-Item Hand Eczema Impact Scale Was Tested in 258 Adults
Doctor’s Notes · Life in Motion · Evidence Review
Editorial disclosure: The featured scene is an AI-created illustration of fictional people and work settings. It is not a patient, diagnosis, before-and-after image or Dr. Arsy #003 treatment result.
Why this study is useful
This paper asks a focused question about work, daily activity or measurement. Keeping the population, denominator, design and timepoint visible prevents a useful result from becoming an exaggerated promise.
Study snapshot
| Study element | Reported detail |
|---|---|
| Population | 20 adults in cognitive interviews and 258 phase-2b trial participants for psychometric testing |
| Design | Patient-reported-outcome development and validation study |
| Timepoint | Interviews followed by repeated trial assessments |
| Key result | Internal consistency was at least 0.89, test–retest ICC at least 0.79, concurrent correlations 0.66–0.87, and a 1.3-point improvement was proposed for total and daily-activity scores |
What the numbers mean
Internal consistency was at least 0.89, test–retest ICC at least 0.79, concurrent correlations 0.66–0.87, and a 1.3-point improvement was proposed for total and daily-activity scores.
Important limitation: Psychometric data came from a treatment-trial population, sponsor involvement should be considered, and a score threshold supports measurement rather than diagnosing cause or promising outcome.
Questionnaires, examinations, photographs, patch tests and administrative records answer different questions. A screening result can guide the next step, but it does not diagnose the cause of one person’s rash. An association can identify a pattern worth investigating, but it does not prove that a single task, material or personal factor caused every event.
Practical questions for a busy life
- What exposure happens before symptoms: water, soap, gloves, friction, heat, dust, resin, adhesive or another material?
- Which body sites are involved, and does the distribution match the suspected task or equipment?
- What should be tracked: visible severity, sleep, daily function, missed work, presenteeism or safe participation?
- Would occupational-health review, clinician examination or clinician-directed patch testing change the plan?
- What requires prompt medical evaluation, including rapidly spreading redness, drainage, fever, severe pain or major loss of function?
Primary and authoritative sources
- Primary medical research record: PubMed PMID 39428453
- NIAMS: atopic dermatitis overview
- American Academy of Dermatology: skin-care guidance
- NIOSH: occupational skin-exposure recommendations
PubMed indexing is not NIH endorsement of a study’s interpretation, this article or any product.
Where a cosmetic moisturizer fits
Dr. Arsy #003 is a cosmetic moisturizer for hydration, moisture-barrier support and dry-skin comfort. This study did not test #003, and outside research does not become a product result. #003 is not an eczema medicine and this article makes no treatment, cure, prevention, pediatric-safety or 24-hour claim.
Bottom line
The responsible conclusion is narrow: preserve the denominator, comparator, timepoint and limitations, then use the evidence to ask better clinical and exposure-control questions rather than promise a universal result.